BRTX

BioRestorative Therapies, Inc. BRTX

Net profit

EBITDA

P/E Ratio

Capitalization

Performance

Periode BRTX ARDS BPTH CELZ CING CNTX ENDV ENSC KPRX PPBT
6M -10.67 % 1 300.00 % -54.60 % 62.33 % -1.00 % 61.45 % -50.00 % 19.39 % -1.09 % -75.25 %
YTD 6.72 % 1 300.00 % -94.08 % 50.38 % -21.96 % 15.97 % -85.71 % -71.64 % -23.74 % -86.52 %
1Y -5.91 % 1 300.00 % -93.97 % -22.80 % -11.75 % -30.65 % -90.00 % -8.24 % -11.94 % -84.91 %
3Y -52.68 % -99.86 % -99.89 % -12.28 % -98.49 % 26.61 % -98.75 % -99.69 % -95.08 % -98.44 %
5Y -97.16 % -99.98 % -99.92 % -71.05 % -99.63 % -72.94 % -99.88 % -99.99 % -99.80 % -99.28 %
10Y -99.99 % -99.99 % -100.00 % -99.96 % -99.63 % -72.94 % -100.00 % -99.99 % -99.98 % -99.90 %
From the beginning -100.00 % -99.99 % -100.00 % -99.96 % -99.63 % -72.94 % -100.00 % -99.99 % -99.99 % -99.90 %

Dividend